GRK2 inhibitors (GSK)

N/A

Report date: 2025/01/26 18:36:04
NME

Base Information

Drug NameGRK2 inhibitors (GSK)
Drug Alias NameGSK-24
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-adrenergic receptor kinase 1 inhibitors
TargetsBeta-adrenergic receptor kinase 1
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Llc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Llc
Inactive CompaniesN/A
Active IndicationsHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A